Circulating tumor cells in metastatic breast cancer: Are they a strong and independent predictor of poor progression-free and overall survival?

被引：0
|
作者：
Wallwiener, Markus
Schneeweiss, Andreas
Baccelli, Irene
Riethdorf, Sabine
Pantel, Klaus
Marme, Frederik
Schott, Sarah
Trumpp, Andreas
Taran, Florin-Andrei
Hahn, Markus
Schuetz, Florian
Mueller, Volkmar
Rack, Brigitte Kathrin
Sohn, Christof
Solomayer, Erich-Franz
Janni, Wolfgang
Hartkopf, Andreas D.
Fehm, Tanja N.
机构：
[1] Heidelberg Univ, Dept Obstet & Gynaecol, Heidelberg, Germany
[2] Natl Ctr Tumor Dis, Heidelberg, Germany
[3] German Canc Res Ctr, HI STEM, Heidelberg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Inst Tumor Biol, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Inst Tumor Biol, Ctr Med Expt, Hamburg, Germany
[6] Univ Heidelberg Hosp, Dept Obstet & Gynecol, Heidelberg, Germany
[7] Heidelberg Univ, Dept Gynecol & Obstet, Natl Ctr Tumor Dis, Heidelberg, Germany
[8] Univ Tubingen, Dept Gynecol & Obstet, Tubingen, Germany
[9] Univ Tubingen Hosp, Dept Gynecol & Obstet, Tubingen, Germany
[10] Univ Heidelberg Hosp, Heidelberg, Germany
[11] Univ Med Ctr Hamburg, Hamburg, Germany
[12] Klinikum Ludwig Maximilians Univ, Dept Gynecol & Obstet, Munich, Germany
[13] Univ Saarland, Homburg, Germany
[14] Univ Klinikum Dusseldorf, Dept Gynecol & Obstet, Dusseldorf, Germany
[15] Univ Tubingen, Dept Obstet & Gynecol, Tubingen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1090
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Circulating tumor cells are a reliable predictor of progression free survival and overall survival during therapy of patients with metastatic breast cancer
    Hayes, DF
    Miller, MC
    Cristofanilli, M
    Ellis, MJ
    Stopek, A
    Allard, WJ
    Matera, J
    Doyle, GV
    Terstappen, LWWM
    Budd, GT
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S225 - S225
  • [2] Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
    Cohen, Steven J.
    Punt, Cornelis J. A.
    Iannotti, Nicholas
    Saidman, Bruce H.
    Sabbath, Kert D.
    Gabrail, Nashat Y.
    Picus, Joel
    Morse, Michael
    Mitchell, Edith
    Miller, M. Craig
    Doyle, Gerald V.
    Tissing, Henk
    Terstappen, Leon W. M. M.
    Meropol, Neal J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) : 3213 - 3221
  • [3] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [4] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [5] Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients
    Benezeder, Theresa
    Tiran, Verena
    Treitler, Alexandra A. N.
    Suppan, Christoph
    Rossmann, Christopher
    Stoeger, Herbert
    Cote, Richard J.
    Datar, Ram H.
    Balic, Marija
    Dandachi, Nadia
    [J]. ONCOTARGET, 2017, 8 (54) : 92483 - 92496
  • [6] EFFECT OF REDUCTION OF CIRCULATING TUMOR CELLS (CTCS) ON PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER (MBC) PATIENTS
    Giuliano, M.
    Giordano, A.
    Handy, B. C.
    Ueno, N.
    Andreopoulou, E.
    Alvarez, R. H.
    Valero, V.
    Hortobagyi, G. N.
    Reuben, J.
    Cristofanilli, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 32 - 33
  • [7] Circulating Tumor Cells in Metastatic Breast Cancer: Monitoring Response to Chemotherapy and Predicting Progression-Free Survival
    Cheng, Jian-ping
    Yan, Ying
    Wang, Xiang-yi
    Lu, Yuan-li
    Yuan, Yan-hua
    Wang, Xiao-li
    Jia, Jun
    Ren, Jun
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 201 - 210
  • [8] Circulating Tumor Cells in Metastatic Breast Cancer:Monitoring Response to Chemotherapy and Predicting Progression-Free Survival
    Jian-ping Cheng
    Department of Medical Oncology
    [J]. Chinese Journal of Cancer Research, 2010, 22 (03) : 201 - 210
  • [9] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
  • [10] Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer
    Bauernhofer, T
    Zenahlik, S
    Hofmann, G
    Balic, M
    Resel, M
    Pirchmoser, R
    Regitnig, P
    Ambros, P
    Dandachi, N
    Samonigg, H
    [J]. ONCOLOGY REPORTS, 2005, 13 (02) : 179 - 184
12345